Provenienza dei contatti di primo grado di Martijn Bax
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
AstraZeneca BV
1
| Subsidiary | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Martijn Bax tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
NewAmsterdam Pharma Holding BV
 NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million. | Biotechnology | Corporate Officer/Principal | |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Vrije Universiteit Amsterdam | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Paesi Bassi | 4 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Marc Ditmarsch | 4 |
- Borsa valori
- Insiders
- Martijn Bax
- Connessioni Società
